the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy: a Randomized Controlled Trial

To investigate the effectiveness of carbetocin on reducing intraoperative blood loss during abdominal myomectomy

Inclusion Criteria:

• • Patients presenting for abdominal myomectomy with documented uterine fibroids on pelvic imaging

  • Age ≥ 25 years and ≤ 50 years
  • Pre-operative hemoglobin >10 g/dl
  • Ability to understand and the willingness to sign a written informed consent.
  • Admissible medical/surgical history
  • Five or less symptomatic uterine myomas
  • symptomatic stage 3 to 6 fibroids, according to FIGO staging

Exclusion Criteria:

• • Post-menopausal women

  • Patients with known bleeding/clotting disorders
  • Patients with a history of gynecologic malignancy
  • Hypertension.
  • Cardiac and Pulmonary diseases.
  • History of allergic reactions attributed to carbetocin